Other

Cranius LLC

Malwarebytes Corporation

Nathan Earl Scott

Owen Friesen

Conner Delahanty

John Cai

Charles Eugene Watkins

Charlotte Quinn

Elayna Williams

Ashley Hinga

Mark Gonzales

Mark William Patton

Owen Churchill

Sherab Giovannini

Ramon Royo Gutierrez

A bidirectional electroosmotic pump may be provided. The bidirectional electroosmotic pump may be made of materials that are biocompatible and non-ferrous. The bidirectional electroosmotic pump may be part of an implantable medical device for the purpose of medicine delivery. The bidirectional electroosmotic pump may contain a working fluid and may facilitate the delivery of a separate payload fluid. In an exemplary embodiment, the bidirectional pump may contain bellows which may allow the pump to deliver the payload fluid through a series of valves and/or catheters. In another embodiment the bidirectional electroosmotic pump may contain a pump sensing mechanism to monitor the state of the pump.

Pump for implantable medical devices

Bracelet

An anti-malware application analyzes behavior of an executing process to identify ransomware. The anti-malware application detects an untrusted process requesting enumeration of a directory of user files and causes the untrusted process to initially operate on a decoy file that mimics the user files. If the behavior of the untrusted process with respect to the decoy file is indicative of ransomware, the process can be terminated without loss of the user files. The decoy file may be deployed in a way that is undetectable to the user.

Behavior-based ransomware detection using decoy files

A pipe flashing protector for protecting the vulnerable joint between a vent pipe and the roof flashing for a building, house or other architectural structure to prevent wear and decay of the joint and more specifically to protect the joint from ultraviolet light, moisture, and debris.

Pipe flashing protector

A method of treating and a composition for treating female sexual arousal dysfunction, comprising administering to the patient a unit dose of a formulation comprising an effective amount of a prostaglandin, selected from prostaglandin E,, prostaglandin E,, pharmaceutically acceptable salts thereof and physiologically acceptable esters thereof, wherein the prostaglandin is formulated with prostaglandin F,, together with a pharmaceutically acceptable delivery medium and/or a lubricant.

Prostaglandin E1/F2 in combination with prostaglandin F2&agr; for enhancing female sexual arousal

The present invention relates to the treatment of impotence, and, more particular, to devices for the delivery of a clinicially effective amount of prostaglandin PGE.sub.2 through the urethral mucosa for the treatment of impotence. The device is a solid or porous wand coated with an effective amount of PGE.sub.2 in a suitable carrier. The wand is sized for insertion into the urethra and the subsequent release and absorption of the PGE.sub.2 through the urethral mucosa. In the alternative, the device is a tubular urethral insert through which a unit dosage of a liquid composition containing the PGE.sub.2 is delivered.

Prostaglandin E2 treatment of impotence

Disclosed herein is method of treating and a composition for treating erectile dysfunction in a male patient by administering to the patient a unit dose of a formulation comprising an erectile dysfunction treating amount of a prostaglandin, namely prostaglandin E.sub.1, prostaglandin E.sub.2, or pharmaceutically acceptable salts or derivatives thereof, wherein the prostaglandin is formulated with a small amount of prostaglandin F.sub..alpha.2 together with a pharmaceutically acceptable delivery medium and/or a lubricant.

Prostaglandin E.sub.2 /F.sub.2.alpha.  combination for treating impotence

Disclosed are compositions and methods for the treatment of male impotence, wherein erectile dysfunction is alleviated by administering a pharmaceutically acceptable formulation containing prostaglandin PGE.sub.2. An antidote for the effects of administration of the PGE.sub.2, or for treating priapism of other etiology, is also disclosed.

Growing community of inventors

Fullerton, CA, United States of America

Nathan Earl Scott